cas 1301714-23-7|| where to buy N-Methyl-1-(trifluoromethyl)cyclopropanamine hydrochloride

Nom du produit:N-Methyl-1-(trifluoromethyl)cyclopropanamine hydrochloride

IUPAC Name:N-methyl-1-(trifluoromethyl)cyclopropan-1-amine hydrochloride

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM319385-1g	3-4 Weeks	ŵǶƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1301714-23-7 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1301714-23-7; Formule moléculaire:C5H9ClF3N; Point de fusion:-; Code SMILES:CNC1(C(F)(F)F)CC1.[H]Cl; Densité:

: Numéro de catalogue:CM319385; Poids moléculaire:175.58; Point d'ébullition:; N° Mdl:MFCD18837771; Stockage:

: Fluorinated Compounds; Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.